GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (OTCPK:CHGCY) » Definitions » Cyclically Adjusted PB Ratio

Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Cyclically Adjusted PB Ratio : 7.69 (As of Jun. 09, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Chugai Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2024-06-09), Chugai Pharmaceutical Co's current share price is $15.07. Chugai Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $1.96. Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 7.69.

The historical rank and industry rank for Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

CHGCY' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.33   Med: 7.95   Max: 15.27
Current: 8.05

During the past years, Chugai Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 15.27. The lowest was 4.33. And the median was 7.95.

CHGCY's Cyclically Adjusted PB Ratio is ranked worse than
90.84% of 742 companies
in the Drug Manufacturers industry
Industry Median: 1.875 vs CHGCY: 8.05

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Chugai Pharmaceutical Co's adjusted book value per share data for the three months ended in Mar. 2024 was $3.331. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.96 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Chugai Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Chugai Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.94 13.80 8.53 6.68 9.31

Chugai Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.30 7.62 8.32 9.31 9.76

Competitive Comparison of Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Chugai Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=15.07/1.96
=7.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chugai Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Chugai Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.331/107.2000*107.2000
=3.331

Current CPI (Mar. 2024) = 107.2000.

Chugai Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.752 98.000 1.916
201409 1.659 98.500 1.806
201412 1.527 97.900 1.672
201503 1.507 97.900 1.650
201506 1.513 98.400 1.648
201509 1.561 98.500 1.699
201512 1.571 98.100 1.717
201603 1.672 97.900 1.831
201606 1.822 98.100 1.991
201609 1.891 98.000 2.069
201612 1.698 98.400 1.850
201703 1.748 98.100 1.910
201706 1.837 98.500 1.999
201709 1.856 98.800 2.014
201712 1.867 99.400 2.014
201803 2.041 99.200 2.206
201806 2.025 99.200 2.188
201809 2.009 99.900 2.156
201812 2.052 99.700 2.206
201903 2.084 99.700 2.241
201906 2.233 99.800 2.399
201909 2.303 100.100 2.466
201912 2.383 100.500 2.542
202003 2.415 100.300 2.581
202006 2.563 99.900 2.750
202009 2.667 99.900 2.862
202012 2.872 99.300 3.100
202103 2.750 99.900 2.951
202106 2.906 99.500 3.131
202109 3.011 100.100 3.225
202112 3.173 100.100 3.398
202203 3.181 101.100 3.373
202206 2.968 101.800 3.125
202209 2.777 103.100 2.887
202212 3.210 104.100 3.306
202303 3.269 104.400 3.357
202306 3.255 105.200 3.317
202309 3.157 106.200 3.187
202312 3.431 106.800 3.444
202403 3.331 107.200 3.331

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Chugai Pharmaceutical Co  (OTCPK:CHGCY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Chugai Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding Ltd, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and COVID-19.

Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Headlines